Refractory bleeding after endoscopic sphincterotomy: a new indication for recombinant factor VII therapy?
Romero-Castro
R
R
Department of Gastroenterology, Virgen Macarena University Hospital, Seville, Spain.
Jiménez-Sáenz
M
M
Pellicer-Bautista
F
F
Herrerías-Gutiérrez
J M
JM
D005167:Factor VII / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D019106:Postoperative Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D011994:Recombinant Proteins / Q000627:therapeutic use; D016717:Sphincterotomy, Endoscopic / Q000009:adverse effects*
D011994:Recombinant Proteins; D005167:Factor VII